Program Edukasi Tulus, Edukasi Tuberkulosis Pada Pasien Lupus di Rumah Sakit Hasan Sadikin

Alveron Andreas Tear, Mohammad Abyan Alfi, Fadhilla Zakya Azzahra, Frida Dwi Lestari, Intan Widya Astuti, Khalista Ismaya Maharani, Muhammad Faza Faliq, Muhammad Naufal A, Rahmania Devina Putri, Siti Azyyati Nur Shadrina, Viki Fadillah, Bethy Suryawathy Hernowo, Laniyati Hamijoyo, Edhyana Sahiratmadja

Sari


ABSTRAK

 

Pasien lupus eritematosus sistemik (LES) memiliki risiko lebih tinggi terhadap infeksi tuberkulosis (TB) akibat penggunaan obat lupus dan penyakitnya. Di Indonesia, prevalensi TB aktif pada pasien LES mencapai 10,2%, jauh lebih tinggi dibandingkan populasi umum. Kurangnya pengetahuan pasien mengenai TB dapat menyebabkan keterlambatan diagnosis dan pengobatan yang optimal. Tujuan: Melakukan program edukasi Tuberkulosis pada pasien lupus yang diberi nama TULUS dalam meningkatkan pemahaman pasien LES tentang risiko dan pencegahan TB dan mengevaluasi efektivitas program edukasi tersebut. Kami melaksanakan kegiatan edukasi berbasis penyuluhan secara langsung dengan media pendukung berupa poster dan flyer. Pengetahuan pasien diukur dengan pre-test dan post-test. Kegiatan ini dilakukan di Poli Reumatologi, Rumah Sakit Dr. Hasan Sadikin Bandung. Hasil test dianalisis menggunakan uji Wilcoxon Signed Ranks untuk mengukur pengetahuan pasien. Sebanyak 21 pasien LES berpartisipasi dalam kegiatan edukasi TULUS. Terdapat peningkatan yang signifikan pada median skor pengetahuan dari 7 pada pre-test menjadi 9 pada post-test (p=0,001). Program edukasi TULUS terbukti efektif dalam meningkatkan pengetahuan pasien LES mengenai TB. Kegiatan lanjutan perlu dilakukan untuk menilai retensi pengetahuan tentang TB pada pasien LES.

 

Kata Kunci: Lupus Eritematosus Sistemik, Tuberkulosis, Edukasi Kesehatan, Pencegahan TB.

 

 

ABSTRACT

 

Systemic lupus erythematosus (SLE) patients have a higher risk of tuberculosis (TB) infection, due to the use of lupus drugs and the disease activity. In Indonesia, the prevalence of active TB in SLE patients has reached 10.2%, much higher than the general population. Lack of patient knowledge about TB can cause delays in diagnosis and optimal treatment. To evaluate the effectiveness of the Tuberculosis Education in Lupus Patients called TULUS education program in increasing the knowledge of SLE patients about TB risks and prevention. We carried out direct education methods with supporting media in the form of posters and flyers. Patient knowledge was measured before and after the education. The activity was conducted at the Rheumatology Clinic, Dr. Hasan Sadikin General Hospital, Bandung. The pre-test and post-test results were analyzed using the Wilcoxon Signed Ranks test to measure patient knowledge. A total of 21 SLE patients participated in the TULUS education. There was a significant increase in the median knowledge score from 7 on the pre-test to 9 on the post-test (p=0.001). The TULUS education program has proven effective in increasing SLE patients' knowledge about TB. Further activities are needed to assess retention of knowledge about TB in SLE patients.

 

Keywords: Systemic Lupus Erythematosus, Tuberculosis, Health Promotion


Kata Kunci


lupus eritematosus sistemik; tuberkulosis; edukasi kesehatan; pencegahan TB

Teks Lengkap:

Download Artikel

Referensi


Abulfathi, A. A., Decloedt, E. H., Svensson, E. M., Diacon, A. H., Donald, P., & Reuter, H. (2019). Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clinical Pharmacokinetics, 58(9), 1103–1129. https://doi.org/10.1007/s40262-019-00764-2

Ameer, M. A., Chaudhry, H., Mushtaq, J., Khan, O. S., Babar, M., Hashim, T., Zeb, S., Tariq, M. A., Patlolla, S. R., Ali, J., Hashim, S. N., & Hashim, S. (2022). An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. https://doi.org/10.7759/cureus.30330

Astuti, V. W., Nidia, W. H., & Amri, L. F. (2024). Edukasi Kesehatan untuk Meningkatkan Pengetahuan dan Kesadaran Masyarakat tentang TBC di Wilayah Kerja Puskesmas Anak Air Padang. Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM), 7(11), 5030–5041. https://doi.org/10.33024/jkpm.v7i11.17412

Barber, M. R. W., Falasinnu, T., Ramsey-Goldman, R., & Clarke, A. E. (2023). The global epidemiology of SLE: narrowing the knowledge gaps. Rheumatology, 62(Supplement_1), i4–i9. https://doi.org/10.1093/rheumatology/keac610

Barbhaiya, M., Hart, J. E., Malspeis, S., Tedeschi, S. K., VoPham, T., Sparks, J. A., Karlson, E. W., Laden, F., & Costenbader, K. H. (2023). Association of Ultraviolet B Radiation and Risk of Systemic Lupus Erythematosus Among Women in the Nurses’ Health Studies. Arthritis Care & Research, 75(7), 1409–1415. https://doi.org/10.1002/acr.24974

Barik, A. L., Purwaningtyas, R. A., & Astuti, D. (2019). The Effectiveness of Traditional Media (Leaflet and Poster) to Promote Health in a Community Setting in the Digital Era: A Systematic Review. Jurnal Ners, 14(3), 76–80. https://doi.org/10.20473/jn.v14i3.16988

Carvalho, A. C. C., & Kritski, A. L. (2022). Community-based intervention and health education to scale up TB preventive treatment for children. The International Journal of Tuberculosis and Lung Disease, 26(7), 587–589. https://doi.org/10.5588/ijtld.22.0254

Cerqueira, A., Seco, T., Paiva, D., Martins, H., & Cotter, J. (2020). Isoniazid-induced Lupus: When the Cure Can be Lethal. Cureus. https://doi.org/10.7759/cureus.7311

Darmawan, G., Liman, L. M. S., Wibowo, S. A. K., Hamijoyo, L., Apriani, L., Atik, N., Alisjahbana, B., & Sahiratmadja, E. (2024). Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis. Lupus, 33(6), 555–573. https://doi.org/10.1177/09612033241239504

Dima, A., Jurcut, C., Chasset, F., Felten, R., & Arnaud, L. (2022). Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Therapeutic Advances in Musculoskeletal Disease, 14. https://doi.org/10.1177/1759720X211073001

Enríquez-Merayo, E., & Cuadrado, M. J. (2023). Steroids in Lupus: Enemies or Allies. Journal of Clinical Medicine, 12(11), 3639. https://doi.org/10.3390/jcm12113639

Hamijoyo, L., Sahiratmadja, E., Ghassani, N. G., Darmawan, G., Susandi, E., van Crevel, R., Hill, P. C., & Alisjahbana, B. (2022). Tuberculosis Among Patients With Systemic Lupus Erythematosus in Indonesia: A Cohort Study. Open Forum Infectious Diseases, 9(7). https://doi.org/10.1093/ofid/ofac201

Has, E. M. M., Ulfiana, E., Krisnana, I., Arief, Y. S., Mufidah, A., & Fathoni, M. (2020). PROGRAM PAGAR BESI (PENDAMPINGAN KELUARGA SADAR DAN SIAGA TUBERKULOSIS PARU) UNTUK MENCAPAI ZERO TB CASE 2020 DI WILAYAH KERJA PUSKESMAS KLAMPIS NGASEM, KOTA SURABAYA. Jurnal Pengabdian Masyarakat Dalam Kesehatan, 2(2), 36. https://doi.org/10.20473/jpmk.v2i2.20798

He, X., HW, J., Chen, H., HN, Z., Liu, Y., ZW, X., FL, W., SJ, G., JL, H., MK, Y., Yan, W., JY, D., LJ, B., XE, Z., & SC, T. (2017). Systematic Identification of Mycobacterium tuberculosis Effectors Reveals that BfrB Suppresses Innate Immunity. Molecular & Cellular Proteomics : MCP, 16(12), 2243–2253. https://doi.org/10.1074/mcp.RA117.000296

Kasitanon, N., Hamijoyo, L., Li, M. T., Oku, K., Navarra, S., Tanaka, Y., & Mok, C. C. (2022). Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. International Journal of Rheumatic Diseases, 25(11), 1220–1229. https://doi.org/10.1111/1756-185X.14413

Ko, H., Kim, C. J., & Im, S.-H. (2022). T Helper 2-Associated Immunity in the Pathogenesis of Systemic Lupus Erythematosus. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.866549

Kubjane, M., Berkowitz, N., Goliath, R., Levitt, N. S., Wilkinson, R. J., & Oni, T. (2020). Tuberculosis, human immunodeficiency virus, and the association with transient hyperglycemia in Periurban South Africa. Clinical Infectious Diseases, 71(4), 1080–1088. https://doi.org/10.1093/cid/ciz928

Makgopa, S., & Madiba, S. (2021). Tuberculosis Knowledge and Delayed Health Care Seeking Among New Diagnosed Tuberculosis Patients in Primary Health Facilities in an Urban District, South Africa. Health Services Insights, 14. https://doi.org/10.1177/11786329211054035

Mok, C. C., Hamijoyo, L., Kasitanon, N., Chen, D. Y., Chen, S., Yamaoka, K., Oku, K., Li, M. T., Zamora, L., Bae, S.-C., Navarra, S., Morand, E. F., & Tanaka, Y. (2021). The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. The Lancet Rheumatology, 3(7), e517–e531. https://doi.org/10.1016/S2665-9913(21)00009-6

Pan, L., Lu, M.-P., Wang, J.-H., Xu, M., & Yang, S.-R. (2020). Immunological pathogenesis and treatment of systemic lupus erythematosus. World Journal of Pediatrics, 16(1), 19–30. https://doi.org/10.1007/s12519-019-00229-3

Putri, V. S., Apriyali, A., & Armina, A. (2022). Pengaruh Pendidikan Kesehatan terhadap Pengetahuan dan Tindakan Keluarga dalam Pencegahan Penularan Tuberkulosis. Jurnal Akademika Baiturrahim Jambi, 11(2), 226. https://doi.org/10.36565/jab.v11i2.520

Syahputra, A., Abdurrahman, A., AS, E., Hayati, M., Agustina, F., & Harahap, L. K. S. (2024). Penyuluhan tentang Penanggulangan Tuberkulosis Paru dan Sanitasi Rumah Sehat. Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM), 7(12), 5661–5669. https://doi.org/10.33024/jkpm.v7i12.17631

Takamatsu, R., Shimojima, Y., Kishida, D., Ichikawa, T., & Sekijima, Y. (2022). The impact of normal serum complement levels on the disease classification and clinical characteristics in systemic lupus erythematosus. Advances in Rheumatology, 62(1), 49. https://doi.org/10.1186/s42358-022-00283-y




DOI: https://doi.org/10.33024/jkpm.v8i8.19987

Refbacks

  • Saat ini tidak ada refbacks.


Disponsori oleh : Universitas Malahayati Lampung dan DPW PPNI Lampung

Creative Commons License
Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.